Clinical Trial

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The study is being conducted to compare the pharmacokinetics and safety of HRS-7535 in subjects with mild to moderate hepatic impairment and normal hepatic function.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-06; most recent amendment 2026-02-27.
Status change: Recruiting → Completed 2026-02-27
Status change: Not Yet Recruiting → Recruiting 2025-06-12
Trial Details
NCT Number NCT06961643
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Diabetes Mellitus
Enrollment 24 participants
Start Date 2025-06-05
Primary Completion 2026-01-22 (estimated)
Study Completion 2026-01-22 (estimated)
Updated on ClinicalTrials.gov 2026-03-02